Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Renal Cell Carcinoma (RCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06380816
What this trial is testing

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

Who this might be right for
Advanced Solid TumoursSquamous Cell Carcinoma of Head and NeckCarcinoma, Non-Small-Cell Lung+8 more
Cancer Research UK 167
Early research (Phase 1)Looking for participantsNCT06234605
What this trial is testing

HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
HiberCell, Inc. 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06523049
What this trial is testing

Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy

Who this might be right for
Renal Cell CarcinomaImmunotherapyMolecular Targeted Therapy
Hao Zeng 67
Early research (Phase 1)Study completedNCT05788484
What this trial is testing

CDX-585 in Patients With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerGastric CancerHead and Neck Cancer+11 more
Celldex Therapeutics 20
Testing effectiveness (Phase 2)Temporarily pausedNCT06860386
What this trial is testing

Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC

Who this might be right for
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 75
Not applicableLooking for participantsNCT04987086
What this trial is testing

68Ga-PSMA PET in the Renal Cell Carcinoma

Who this might be right for
Renal CancerMetastasesPSMA PET
Xijing Hospital 300
Early research (Phase 1)Looking for participantsNCT06242470
What this trial is testing

MGC026 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced CancerMetastatic Cancer+19 more
MacroGenics 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT05239533
What this trial is testing

Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaKidney CancerAdvanced Renal Cell Carcinoma
Memorial Sloan Kettering Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT01147822
What this trial is testing

Pazopanib Versus Sunitinib in the Treatment of Asian Subjects With Locally Advanced and/or Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Novartis Pharmaceuticals 367
Testing effectiveness (Phase 2)Study completedNCT03241173
What this trial is testing

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced Malignancies
Incyte Biosciences International Sàrl 52
Early research (Phase 1)Ended earlyNCT05641545
What this trial is testing

IVAC-RCC-001: A Personalized Neoantigen Vaccine as Add-on to Standard of Care Checkpoint Inhibitor in Advanced/Metastatic RCC Patients

Who this might be right for
Advanced Renal Cell Carcinoma
SLK Kliniken Heilbronn GmbH 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267
What this trial is testing

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

Who this might be right for
Breast CancerCholangiocarcinomaColorectal Cancer+13 more
Hoffmann-La Roche 534
Early research (Phase 1)Looking for participantsNCT04777994
What this trial is testing

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Who this might be right for
Advanced Solid Tumor Cancer
Calico Life Sciences LLC 248
Testing effectiveness (Phase 2)Study completedNCT02983045
What this trial is testing

A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors

Who this might be right for
MelanomaRenal Cell CarcinomaNon Small Cell Lung Cancer+4 more
Nektar Therapeutics 557
Testing effectiveness (Phase 2)UnknownNCT04958473
What this trial is testing

Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer

Who this might be right for
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
Tianjin Medical University Second Hospital 40
Testing effectiveness (Phase 2)Study completedNCT02667886
What this trial is testing

Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
X4 Pharmaceuticals 74
Testing effectiveness (Phase 2)Study completedNCT00923845
What this trial is testing

Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer

Who this might be right for
Renal Cell CarcinomaGraft-Versus-Host DiseaseEngraftment Syndrome
National Cancer Institute (NCI) 25
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Large-scale testing (Phase 3)Study completedNCT01265901
What this trial is testing

IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Immatics Biotechnologies GmbH 339
Not applicableStudy completedNCT01390519
What this trial is testing

A Norwegian Observational Trial Evaluating the Treatment of Advanced Renal Cell Cancer Patients Under Treatment of Afinitor

Who this might be right for
Metastatic Renal Cell Carcinoma (mRCC)
Novartis Pharmaceuticals 30
Next Page